Evidence map›Paper›PMID 34403374›Full record

ArticleJCI insight2021

Th1 polarization defines the synovial fluid T cell compartment in oligoarticular juvenile idiopathic arthritis.

Amélie M Julé, Kacie J Hoyt, Kevin Wei, Maria Gutierrez-Arcelus, Maria L Taylor, Julie Ng, James A Lederer, Siobhan M Case, Margaret H Chang, Ezra M Cohen and 15 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. The 'TNature reviews. Rheumatology · 2025
    Review
  13. Article
  14. Review
  15. Article
  16. Methylation of T and B Lymphocytes in Autoimmune Rheumatic Diseases.Clinical reviews in allergy & immunology · 2024
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 4 institutions in 1 country.

Amélie M JuléDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Kacie J HoytDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Kevin WeiDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Maria Gutierrez-ArcelusDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Maria L TaylorDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Julie NgDivision of Pulmonary and Critical Care Medicine, and.
James A LedererDepartment of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Siobhan M CaseDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Margaret H ChangDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Ezra M CohenDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Fatma DedeogluDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Melissa M HazenDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Jonathan S HausmannDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Olha HalyabarDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Erin JanssenDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Jeffrey LoDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Mindy S LoDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Esra MeidanDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Jordan E RobertsDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Mary Beth F SonDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Robert P SundelDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Pui Y LeeDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Talal ChatilaDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Peter A NigrovicDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Lauren A HendersonDivision of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Boston Children's Hospital · USBrigham and Women's Hospital · USBroad Institute · USPulmonary and Critical Care Associates · US

Funding

RESPIRATORY RESEARCHT32HL007633 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI George R Washko · 1985 to 2026
$14.9M
MOLECULAR BASIS OF ALLERGIC AND IMMUNOLOGIC DISEASET32AI007512 · NIAID · CHILDREN'S HOSPITAL BOSTON · PI Janet Chou, Peter A Nigrovic · 1996 to 2026
$13.1M
Joint Biology Consortium Resource-based CenterP30AR070253 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Peter A Nigrovic, Jeffrey Andrew Sparks · 2016 to 2026
$9.4M
Bridging the gap between GWAS and mechanism in JIAR01AR073201 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Peter A Nigrovic · 2019 to 2026
$3.2M
T resident memory cells in arthritisR01AR075906 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI NIGROVIC, PETER A · 2019 to 2023
$2.1M
The Reprogramming of Regulatory T cells to a Th17 Phenotype in Systemic Juvenile Idiopathic ArthritisK08AR073339 · NIAMS · BOSTON CHILDREN'S HOSPITAL · PI HENDERSON, LAUREN A · 2018 to 2022
$840k
Pathogenic fibroblast differentiation in rheumatoid arthritisK08AR077037 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI WEI, KEVIN S · 2020 to 2024
$799k
NHLBI NIH HHS T32 HL007633NIAID NIH HHS T32 AI007512NIAMS NIH HHS K08 AR073339NIAMS NIH HHS K08 AR077037NIAMS NIH HHS P30 AR070253NIAMS NIH HHS R01 AR073201NIAMS NIH HHS R01 AR075906
6 · The paper itself

Abstract

Oligoarticular juvenile idiopathic arthritis (oligo JIA) is the most common form of chronic inflammatory arthritis in children, yet the cause of this disease remains unknown. To understand immune responses in oligo JIA, we immunophenotyped synovial fluid T cells with flow cytometry, bulk RNA-Seq, single-cell RNA-Seq (scRNA-Seq), DNA methylation studies, and Treg suppression assays. In synovial fluid, CD4+, CD8+, and γδ T cells expressed Th1-related markers, whereas Th17 cells were not enriched. Th1 skewing was prominent in CD4+ T cells, including Tregs, and was associated with severe disease. Transcriptomic studies confirmed a Th1 signature in CD4+ T cells from synovial fluid. The regulatory gene expression signature was preserved in Tregs, even those exhibiting Th1 polarization. These Th1-like Tregs maintained Treg-specific methylation patterns and suppressive function, supporting the stability of this Treg population in the joint. Although synovial fluid CD4+ T cells displayed an overall Th1 phenotype, scRNA-Seq uncovered heterogeneous effector and regulatory subpopulations, including IFN-induced Tregs, peripheral helper T cells, and cytotoxic CD4+ T cells. In conclusion, oligo JIA is characterized by Th1 polarization that encompasses Tregs but does not compromise their regulatory identity. Targeting Th1-driven inflammation and augmenting Treg function may represent important therapeutic approaches in oligo JIA.

Indexed as

Cell PolarityAdolescentArthritis, JuvenileCase-Control StudiesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesChildChild, PreschoolDNA MethylationFemaleHumansImmunophenotypingInfantIntraepithelial LymphocytesMaleSequence Analysis, RNAAutoimmunityImmunologyRheumatologyT cellsTh1 response

Identifiers

PMID34403374
PMCPMC8492302
OpenAlexW3195271982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.